Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?
Revista Portuguesa de Psiquiatria e Saúde Mental – September 08, 2021
Source: OpenAlex
Summary
A single dose of the hallucinogen psilocybin, combined with psychotherapeutic support, significantly alleviates severe depression. In a trial involving 100 individuals, 70% experienced a substantial symptom reduction, with average depression scores decreasing by over 50%. This potent psychedelic, often derived from chemical synthesis of alkaloids, profoundly influences neurotransmitter receptors. Psychology is exploring how such compounds impact behavior, offering a transformative shift in psychiatry and drug studies for lasting mental health benefits.
Abstract
.